Evotec SE today announced that new high-throughput screening (“HTS”) facilities at the Company’s headquarters in Hamburg, as well as additional equipment for investigating the safety and efficacy of new therapeutic candidates have been put into operation. Hamburg’s Senator for Economic Affairs, Dr Melanie Leonhard, visited Evotec’s Manfred Eigen Campus to see how the expanded HTS facilities in combination with technologies of the future will be used to accelerate drug discovery. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-accelerating-drug-discovery-with-screening-technologies-of-the-future-through-erdfreact-eu-grant-6296